Valuation : DUCAT VENTURES

Market Cap 6.15M 8.33M 7.16M 6.75M 11.5M 792M 11.55M 79.95M 30.9M 404M 31.26M 30.58M 1.28B P/E 2024
-9.76x
P/E 2025 -1.76x
Enterprise Value 5.11M 6.92M 5.96M 5.61M 9.56M 659M 9.6M 66.46M 25.69M 336M 25.99M 25.42M 1.06B EV / Sales 2024
19.4x
EV / Sales 2025 5.09x
Free-Float
88.62%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 66 04/08/2014
Director of Finance/CFO 65 31/10/2024
Chief Tech/Sci/R&D Officer 53 -
Director TitleAgeSince
Director/Board Member 53 03/07/2018
Director/Board Member 66 04/08/2014
Chairman 75 31/12/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.94%+0.31%+40.04%+103.25% 69.19B
-0.07%-3.93%+32.54%+75.96% 62.97B
+3.13%+1.82%-12.41%+386.53% 27.27B
-0.54%-5.46%-3.87%-16.80% 24.78B
-0.93%-1.29%+25.30%+16.70% 25.8B
-1.43%-1.89%+21.32%-17.67% 20.11B
-4.27%+2.67%+219.02%+362.48% 18.47B
-1.43%-1.80%-8.64%+537.09% 14.88B
+1.14%-0.38%+52.32%+165.17% 14.29B
Average -0.57%-0.31%+40.62%+179.19% 30.86B
Weighted average by Cap. -0.46%-0.76%+36.47%+141.03%

Financials

2024 2025
Net sales 870K 1.18M 1.01M 955K 1.63M 112M 1.63M 11.32M 4.37M 57.13M 4.43M 4.33M 181M 1.17M 1.58M 1.36M 1.28M 2.18M 150M 2.19M 15.17M 5.86M 76.56M 5.93M 5.8M 243M
Net income -1.8M -2.44M -2.1M -1.98M -3.38M -233M -3.39M -23.48M -9.07M -119M -9.18M -8.98M -375M -3.89M -5.27M -4.53M -4.27M -7.28M -501M -7.31M -50.6M -19.56M -255M -19.79M -19.36M -809M
Net Debt -739K -1M -861K -811K -1.38M -95.25M -1.39M -9.61M -3.72M -48.53M -3.76M -3.68M -154M -1.04M -1.4M -1.21M -1.14M -1.94M -134M -1.95M -13.49M -5.21M -68.09M -5.27M -5.16M -216M
Logo DUCAT VENTURES
OptiBiotix Health Plc is a life sciences company. The Company is engaged in the development of microbial strains, compounds, and formulations, which are used as active ingredients and supplements. It is focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. It is also developing its own range of consumer supplements and health products. Its areas of focus include obesity, cardiovascular health, and diabetes. Its products include SlimBiome, CholBiome, SweetBiotix, WellBiome, OptiBiotics and SlimBiome X3. SlimBiome offers a natural, scientifically supported, non-pharmaceutical approach to reducing hunger and cravings. CholBiome contains Lactobacillus plantarum LPLDL as the only active ingredient, focusing on healthy cholesterol maintenance and delivering tangible health benefits. SweetBiotix is a zero or low-calorie, prebiotic, and a smarter alternative to sugar and existing sweeteners.
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!